InvestorsHub Logo
Followers 165
Posts 19880
Boards Moderated 2
Alias Born 12/09/2004

Re: BIOChecker4 post# 208769

Saturday, 09/07/2019 2:17:08 PM

Saturday, September 07, 2019 2:17:08 PM

Post# of 463849

Trying to find possible responders in order to skew the results. One of the oldest tricks in the book.

Trying to find possible responders is the very definition of precision medicine.

It is exactly what Anavex should be doing.

However, in this case it appears that Anavex is trying to make sure the AD diagnosis is as correct as possible to PREVENT skewing of the results by misdiagnosis. The technologies for diagnosing and confirming AD have improved considerably in the last two years.

They also appear to be taking more baseline data than in the past to validate additional measures of disease progress.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News